Logo image
Back
An interim analysis of acute treatment adverse events and patient reported quality of life for functional imaging guided salivary gland sparing radiation therapy using diffusion-weighted magnetic resonance imaging
Journal article   Open access   Peer reviewed

An interim analysis of acute treatment adverse events and patient reported quality of life for functional imaging guided salivary gland sparing radiation therapy using diffusion-weighted magnetic resonance imaging

Katelyn Cahill, Catriona Hargrave, Kane Miller, Alexandria Leppien, Claudia Chapple, Jasmine Meaghan, Michelle Phan, Mark Denham, Patrick O'Connor, Alan Ho, …
Physics and Imaging in Radiation Oncology, Vol.41, pp.1-8
2026
DOI: https://doi.org/10.1016/j.phro.2026.101095
pdf
An interim analysis of acute treatment adverse events and patient reported quality of life for functional imaging guided salivary gland sparing radiation therapy using diffusion-weighted magnetic resonance imaging3.71 MBDownloadView
Published Version Open Access CC BY-NC-ND V4.0

Abstract

Apparent diffusion coefficient Biological at-risk Volume Diffusion weighted MRI Functional imaging guided radiotherapy Head and neck cancer Parotid-sparing Patient reported outcomes xerostomia
Background and purpose Evolving evidence suggests that regional sparing of the parotid gland during radiation therapy could reduce radiation-induced xerostomia in head and neck cancer. This interim analysis investigates the functional relationship between the diffusion-weighted magnetic resonance imaging (DW-MRI) derived parotid gland biological at-risk volume (BRV) dose and acute adverse events, including patient-reported quality of life (QoL). Materials and methods Twenty-four head and neck cancer patients underwent MRI-simulation to delineate parotid gland BRVs using DW-MRI derived apparent diffusion coefficient measurements. Dose was optimised, sparing the parotid gland BRV. Clinician-reported acute adverse events (xerostomia, dysphagia, oral pain) were recorded and patient-reported QoL was assessed using University of Washington QoL Questionnaire v4.1 with Radiation Therapy Oncology Group modification. Adverse events were quantified using area under the curve and time to side effect peaks were calculated and analysed. Results A moderate positive correlation trend was observed between contralateral BRV mean dose and xerostomia area under the curve, although this did not reach statistical significance (r = 0.34, p = 0.13). There was a strong relationship between the contralateral BRV sector and days to peak dysphagia (r = 0.56, p = 0.005). Low- and high-dose grouped analysis revealed a trend toward significance for time to peak xerostomia (p = 0.059). There were no significant associations with the ipsilateral parotid gland BRVs. Conclusion Findings suggest a potential functional-dose relationship between the contralateral BRV mean dose and acute xerostomia. Ongoing follow-up will determine whether the suggestive trends observed in the acute phase strengthen with long-term recovery time.

Details

Metrics

1 Record Views
Logo image